Solid Biosciences Inc. (SLDB)
5.13
-0.46 (-8.23%)
At close: Mar 03, 2025, 3:59 PM
5.13
0.00%
After-hours: Mar 03, 2025, 07:57 PM EST
Solid Biosciences Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 |
| Revenue | n/a | 8.09M | 13.62M | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 76.56M | 2.41M | 58.74M | 3.92M | 2.82M | 1.57M | 448K | 56K | n/a |
| Gross Profit | -76.56M | 5.69M | -45.12M | -3.92M | -2.82M | -1.57M | -448K | -56K | n/a |
| Operating Income | -104.31M | -106.45M | -72.25M | -88.41M | -119.32M | -75.69M | -54.86M | -25.58M | -6.56M |
| Interest Income | 7.14M | 2.62M | 64K | 115K | 1.58M | 619K | 219K | 369K | 3K |
| Pretax Income | -96.02M | -85.98M | -72.19M | -88.29M | -117.22M | -74.8M | -53.18M | -23.77M | -6.66M |
| Net Income | -96.02M | -65.51M | -72.12M | -90.12M | -115.64M | -74.8M | -52.12M | -21.54M | -6.38M |
| Selling & General & Admin | 27.75M | 28.95M | 27.14M | 21.58M | 24.58M | 17.72M | 14.95M | 5.46M | 2.37M |
| Research & Development | 76.56M | 78.42M | 58.74M | 64.88M | 94.74M | 57.97M | 39.91M | 20.12M | 4.19M |
| Other Expenses | n/a | -381K | 2K | 1.94M | 515K | 270K | 1.46M | 1.43M | -103K |
| Operating Expenses | 104.31M | 107.37M | 85.87M | 86.46M | 119.32M | 75.69M | 54.86M | 25.58M | 6.56M |
| Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 104.31M | 107.37M | 85.87M | 86.46M | 119.32M | 75.69M | 54.86M | 25.58M | 6.56M |
| Income Tax | n/a | -20.47M | -64K | 1.83M | -1.58M | 889K | -1.28M | -2.6M | -287K |
| Shares Outstanding (Basic) | 19.88M | 8.51M | 7.12M | 3.46M | 2.69M | 2.22M | 2.15M | 1.28M | 1.28M |
| Shares Outstanding (Diluted) | 19.88M | 8.51M | 7.12M | 3.46M | 2.69M | 2.22M | 2.15M | 1.28M | 1.28M |
| EPS (Basic) | -4.83 | -7.7 | -10.13 | -26.03 | -43.05 | -33.73 | -24.26 | -16.8 | -4.97 |
| EPS (Diluted) | -4.83 | -7.7 | -10.13 | -26.03 | -43.05 | -33.73 | -24.26 | -16.8 | -4.97 |
| EBITDA | -93.43M | -96.87M | -69.29M | -84.37M | -116.49M | -75.69M | -54.41M | -25.52M | 119K |
| Depreciation & Amortization | 2.58M | 2.41M | 2.96M | 3.92M | 2.82M | 1.57M | 448K | 56K | 6.56M |